June 11, 2019 VANCOUVER, British Columbia and MENLO PARK, Calif., /PRNewswire/ — DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization… Read More
This project will leverage Aspect Biosystems’ microfluidic 3D bioprinting platform to develop highly physiological, high-throughput tissues for the accurate and predictive screening of immuno-therapeutics targeting difficult-to-treat cancers such as triple… Read More
NZ Technologies announces third peer-reviewed paper on TIPSO touchless image navigation; builds evidence for a technology platform designed for the OR of the future Vancouver, Canada — June 4, 2019… Read More
Touchless image navigation facilitates decision-making in the operating room A recent publication confirms “the utility of touchless image navigation in the sterile field in facilitating decision-making and resource allocation during… Read More
VANCOUVER, British Columbia and MENLO PARK, Calif., June 3, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of novel… Read More
